Funding boost accelerates development of promising rheumatoid arthritis treatment

Long term relief is within reach for people with the debilitating autoimmune disease, Rheumatoid Arthritis (RA), after an $11.5 million grant was awarded to a University of Queensland-led team.

Madrigal wins first U.S. approval for drug to treat liver disease MASH

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH. The pill, called

March 14, 2024

Ad Insights | Our Understanding of IBD Has Come a Long Way—So Have the Options to Treat It

As someone who has been on the front lines of caring for people with inflammatory bowel disease (IBD) for a cumulative 25+ years, I’ve witnessed

August 3, 2024

Study uncovers roles of certain brain cells in Alzheimer’s plaque formation

A study in Nature Neuroscience found that both neurons and oligodendrocytes contribute to amyloid-β plaque burden in Alzheimer’s disease, highlighting new therapeutic targets.

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.